Tilray Inc (NASDAQ:TLRY - Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $1.09 and last traded at $1.10, with a volume of 34362123 shares trading hands. The stock had previously closed at $1.14.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. Canaccord Genuity Group upped their target price on Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Roth Mkm dropped their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research note on Friday, October 11th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $2.70.
Read Our Latest Stock Report on Tilray
Tilray Trading Down 7.1 %
The company has a 50 day moving average of $1.27 and a 200 day moving average of $1.55. The firm has a market cap of $984.54 million, a price-to-earnings ratio of -3.50 and a beta of 2.08. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The firm had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business's revenue was up 8.7% on a year-over-year basis. As a group, research analysts anticipate that Tilray Inc will post -0.2 EPS for the current year.
Insiders Place Their Bets
In related news, CFO Carl A. Merton purchased 26,000 shares of the stock in a transaction that occurred on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, with a total value of $35,360.00. Following the completion of the acquisition, the chief financial officer now directly owns 26,000 shares in the company, valued at approximately $35,360. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.87% of the company's stock.
Institutional Investors Weigh In On Tilray
Several hedge funds and other institutional investors have recently made changes to their positions in TLRY. BNP Paribas Financial Markets increased its position in Tilray by 1,314.1% in the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company's stock worth $3,202,000 after purchasing an additional 1,690,827 shares during the period. Point72 Asset Management L.P. bought a new stake in shares of Tilray during the third quarter worth approximately $1,348,000. XTX Topco Ltd lifted its holdings in Tilray by 1,079.7% in the third quarter. XTX Topco Ltd now owns 281,504 shares of the company's stock valued at $495,000 after buying an additional 257,641 shares during the period. Barclays PLC boosted its stake in Tilray by 600.4% in the third quarter. Barclays PLC now owns 204,144 shares of the company's stock valued at $359,000 after acquiring an additional 174,997 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Tilray by 6.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company's stock worth $2,953,000 after acquiring an additional 107,530 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.